FRONTEO, Inc. is a Tokyo-based data analytics and artificial intelligence company specializing in natural language processing of large volumes of unstructured text. Formerly known as UBIC, Inc., the company provides AI solutions for e-discovery, digital forensics, compliance, and enterprise knowledge management, serving clients in Japan, the United States, and other regions.
In healthcare and life sciences, FRONTEO develops AI platforms that mine scientific literature and clinical information to surface relationships among diseases, targets, and compounds. Its tools support activities such as target identification, drug repurposing hypotheses, biomarker exploration, and safety signal detection, helping researchers navigate complex data and prioritize R&D paths. These capabilities are relevant to pharmaceutical and biotech workflows connected to the chemical industry, where data-driven insights can inform discovery and development decisions.
Also known as UBIC, Inc. and UBIC.
The collaboration aims to enhance drug discovery by combining AI for target identification with compound optimization, reducing R&D risks and accelerating processes.
